Search publications associated with BioLINCC resources

Reset

Additional Filters

YYYY-MM-DD to YYYY-MM-DD

Table Display Options

Add or remove columns from the table.

Add/Remove Columns

Found 244 results in 29 milliseconds — Export these results
Citation (Ascending)
Nazarzadeh M, Bidel Z, Canoy D, Copland E, Wamil M, Majert J, Smith Byrne K, Sundström J, Teo K, Davis BR, Chalmers J, Pepine CJ, Dehghan A, Bennett DA, Smith GD, Rahimi K, Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet 2021 Nov 13;398(10313):1803-1810.
Neehal N, Anand V, Bennett KP. Framework for Research in Equitable Synthetic Control Arms. AMIA Annu Symp Proc 2024 Jan 11;2023:530-539. eCollection 2023.
Nguyen LS, Procopi N, Salem JE, Squara P, Funck-Brentano C. Relation between baseline LDL-cholesterol and cardiovascular outcomes in high cardiovascular risk hypertensive patients: A post-hoc SPRINT data analysis. Int J Cardiol 2019 Jul 1;286:159-161. Epub 2019 Jan 15.
Nguyen LS. Effect of additional antihypertensive medications in patients with high-risk hypertension: a post hoc analysis of the SPRINT (Systolic Blood Pressure Intervention Trial) database. J Clin Hypertens (Greenwich) 2018 Apr;20(4):814-815. Epub 2018 Mar 15.
O'Conor EC, Wang J, Gibney KD, Yu X, Young GR, Jones T, Alexandrov AW, Johnson KC, Cushman WC, Tsao JW. Lowering systolic blood pressure does not increase stroke risk: an analysis of the SPRINT and ACCORD trial data. Ann Clin Transl Neurol 2018 Nov 28;6(1):144-153. doi: 10.1002/acn3.693. eCollection 2019 Jan.
Obi Y, Kalantar-Zadeh K, Shintani A, Kovesdy CP, Hamano T. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial. J Intern Med 2018 Mar;283(3):314-327. Epub 2017 Nov 19.
Obi Y, Kalantar-Zadeh K, Shintani A, Kovesdy CP, Hamano T. In response to 'benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease'. J Intern Med 2018 Jun;283(6):607-610. Epub 2018 Mar 12.
Ochoa-Jimenez R, Viquez-Beita K, Daluwatte C, Zusterzeel R. Sex Differences of Patients With Systemic Hypertension (From the Analysis of the Systolic Blood Pressure Intervention Trial [SPRINT]). Am J Cardiol 2018 Sep 15;122(6):985-993. Epub 2018 Jun 22.
Okonkwo OC, Sui X, Ahmed A. Disease-specific depression and outcomes in chronic heart failure: a propensity score analysis. Compr Ther 2007 Summer;33(2):65-70.
Oxlund CS, Pareek M, Rasmussen BSB, Vaduganathan M, Biering-Sørensen T, Byrne C, Almarzooq Z, Olsen MH, Bhatt DL. Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial. Am J Med 2019 Jul;132(7):840-846. Epub 2019 Feb 2.
Parcha V, Patel N, Kalra R, Kim J, Gutiérrez OM, Arora G, Arora P. Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial. Hypertension 2020 Jun;75(6):1483-1490. Epub 2020 May 4.
Pareek M, Vaduganathan M, Biering-Sørensen T, Byrne C, Qamar A, Almarzooq Z, Pandey A, Olsen MH, Bhatt DL. Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Med 2019 Jun;132(6):733-739. Epub 2019 Jan 16.
Pareek M, Vaduganathan M, Byrne C, Mikkelsen AD, Kristensen AMD, Biering-Sørensen T, Kragholm KH, Omar M, Olsen MH, Bhatt DL. Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT). Eur Heart J Cardiovasc Pharmacother 2022 May 5;8(3):E12-E14.
Patel K, Sui X, Zhang Y, Fonarow GC, Aban IB, Brown CJ, Bittner V, Kitzman DW, Allman RM, Banach M, Aronow WS, Anker SD, Blair SN, Ahmed A. Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. Int J Cardiol 2013 Oct 3;168(3):1905-9. Epub 2013 Feb 4.
Patel KK, Arnold SV, Chan PS, Tang Y, Pokharel Y, Jones PG, Spertus JA. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial). Circ Cardiovasc Qual Outcomes 2017 Apr;10. (4).
Found 244 results in 29 milliseconds — Export these results